Raptor Pharmaceutical Inc. (RPTP) Provides PROCYSBI Launch Update and Second Quarter 2013 Financial Results
8/9/2013 8:59:53 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
NOVATO, Calif., Aug. 8, 2013 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today provided a launch update for PROCYSBI (cysteamine bitartrate) delayed-release capsules and financial results for its second quarter and six months ended June 30, 2013.
Help employers find you! Check out all the jobs and post your resume.
comments powered by